-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
27
2026-03
From March 26 to 27, a delegation led by ELSHEIKH Tarek, Global Director of Resource Development at global beauty giant L’Oréal Group, visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. Li Hongfu, Chairman of Keyuan Pharmaceutical, together with heads of relevant departments, extended a warm welcome. The two sides held in-depth discussions on key issues such as deepening strategic cooperation and jointly expanding into global markets, reaching multiple agreements.
2026-03-27
13
2026-03
As the spring breeze brings warmth and vegetation begins to stir, on the eve of the 48th Arbor Day, Keyuan Pharmaceutical (stock code: 301281.SZ) warmly launched a voluntary tree‑planting initiative, pooling efforts to add new greenery and empower ecological beauty. Employee representatives from various plants and functional departments gathered together, putting the concept of green development into practice through concrete actions and adding a fresh touch of green to the factory grounds.
2026-03-13
10
2026-03
To keep pace with the rapid advancement of AI technology, foster deep integration between AI and pharmaceutical operations, and comprehensively enhance the AI application capabilities of all employees, Keyuan Group organized a series of AI application training sessions for its entire workforce on March 10. Employees of Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical participated in this training, jointly unlocking new skills in AI tool applications and strengthening the talent foundation for the company’s digital and intelligent transformation.
2026-03-10
07
2026-03
The warm spring breeze of March warms hearts, and the graceful elegance of women blossoms anew. As the International Women’s Day on March 8, 2026 approaches, to honor all female employees for their dedication and commitment, enrich their cultural lives, strengthen team cohesion, and foster a strong atmosphere of respect and care for women, Keyuan Pharmaceutical held a fun-filled event for female employees on March 7, themed “The Spring Breeze Is Like You—Shining Brightly.” All the company’s female employees gathered together joyfully, spending a special and delightful time together through lively competitions.
2026-03-07
27
2026-02
From February 26 to 27, Professor Chen Shouwen from Hubei University and his delegation visited Kexuan Pharmaceutical for a visit and exchange. Li Hongfu, Chairman of Kexuan Pharmaceutical, along with his team, provided full-time accompaniment throughout the visit. The two sides held an in-depth discussion on topics including core product R&D processes, market strategies, and industry-university collaboration.
2026-02-27
23
2026-02
The rugged pass ahead seems as solid as iron, yet today we take a step forward and start anew. On February 23, Keyuan Group (Keyuan Pharmaceutical 301281.SZ, Linuo Pharmaceutical) successfully held its 2026 Marketing Special Conference—the “First Lesson of the New Year”—marking a strong start to the resumption of work. All members of the management team, including Chairman Li Hongfu and President Wei Zhiguo, as well as heads of various business units, functional departments, and core key employees, participated in the event. With the theme “Strategic Leadership, Uniting Hearts and Gathering Strength, Tackling Tough Challenges and Breaking Impasses,” the conference set forth the core objectives for 2026 marketing efforts, carefully planned and laid out the year’s overall marketing strategy, and sounded the clarion call for vigorous advancement as we resume work and production in the new year.
2026-02-23
10
2026-02
On February 10, the bidding process for the new round of follow-up procurement of drugs from the first to eighth batches of nationally centralized drug procurement yielded preliminary winning results. This round of follow-up procurement was jointly organized by the National Healthcare Security Administration, with Jiangsu, Henan, and Guangdong provinces serving as joint lead agencies, and was implemented nationwide in a coordinated manner. It achieved “three unifications”—unified procurement rules, standardized operational procedures, and a consistent market scope—marking an important milestone in deepening and systematizing the reform of centralized drug procurement.
2026-02-10
02
2026-02
Weikang Bio visited Keyuan Pharmaceutical to jointly explore new pathways for pharmaceutical R&D!
On February 2, Professor Liu Pingsheng, founder and chairman of Weikang Shengsheng (Beijing) Biotechnology Co., Ltd. (hereinafter referred to as “Weikang Bio”), along with CEO Dr. Zhang Meng and other core team members, paid a visit to Keyuan Pharmaceutical (stock code: 301281.SZ) for an in-depth discussion. Also attending the meeting were Li Hongfu, Chairman of Keyuan Pharmaceutical; Gao Yuankun, Director; and Gao Chunpo, President.
2026-02-02
20
2026-01
On January 20, Keyuan Group held a special meeting in Jinan to discuss its “1+2 Strategic Plan” and the budget targets for 2026. Attending the meeting were Li Hongfu, Chairman of Keyuan Group; Gao Chunpo, President of Keyuan Pharmaceutical; Wei Zhiguo, President of Linuo Pharmaceutical; as well as the group’s core management team and key business personnel. With “strategy-driven leadership and practical implementation as the priority” at its core, the meeting systematically laid out the group’s future development strategy and the roadmap for implementing its annual budget. The meeting also featured the full-time guidance and commentary of Professor Lan Tao, a doctoral graduate from the National University of Defense Technology and an expert in corporate strategic management.
2026-01-20
04
2026-01
On January 14, Wang Bo, founder and chairman of Yaorongquan, and his delegation visited Keyuan Pharmaceutical and Linuo Pharmaceutical. The two sides conducted an in-depth inspection and held a symposium to discuss topics such as industry development trends, corporate product planning, and business strategy. Li Hongfu, chairman of Keyuan Pharmaceutical, and Gao Chunpo, president of the company, accompanied the delegation on the visit and jointly participated in this industry exchange.
2026-01-04
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline